v3.26.1
Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2026
Significant Accounting Policies [Abstract]  
Schedule of Basic and Diluted (Loss) Earnings Per Share

The following table sets forth the computation of basic and diluted (loss) earnings per share (in thousands, except per share data):

 

   Three Months Ended 
   March 31, 
Basic net (loss) income per common share:  2026   2025 
Numerator:        
Net (loss) income  $(4,050)  $16,982 
Net (loss) income   $(4,050)  $16,982 
           
Denominator:          
Weighted average outstanding shares of common share – basic*   223,986    135,217 
(Loss) earnings per common share - basic  $(0.02)  $0.13 
           
Diluted net (loss) income per common share:          
Numerator:          
Net (loss) income  $(4,050)  $16,982 
Net (loss) income  $(4,050)  $16,982 
           
Denominator:          
Weighted average common shares outstanding - basic   223,986    135,217 
Effect of dilutive securities   
-
    17,789 
Weighted average common shares outstanding - diluted   223,986    153,006 
(Loss) earnings per common share - diluted  $(0.02)  $0.11 

 

*The total shares outstanding as of December 31, 2025 was 224,164,254, however the weighted average share calculation does not include 700,000 shares of unvested common stock.
Schedule of Computation of Diluted Net Loss Per Common Share, as Their Effect Would be Anti-Dilutive The following is a summary of the weighted average common stock equivalents for the securities outstanding during the period that have been excluded from the computation of diluted net loss per common share, as their effect would be anti-dilutive (in thousands):
   Three Months Ended 
   March 31, 
   2026 
Warrants   1,363 
Options   4,336 
Unvested restricted common stock   732 
Total potentially dilutive shares   6,431 

 

For the three months ended March 31, 2025, the following table sets forth the dilutive securities included in diluted earnings per share (in thousands):

 

   Three Months Ended 
   March 31, 
   2025 
Warrants   3,523 
Options   13,002 
Unvested restricted common stock   1,264 
Total potentially dilutive shares   17,789